You searched for "network"
Managing sustainability
Planetary health needs to be addressed at a societal level for any meaningful impact to occur. As the global director of sustainability for a law firm, Marion Palmer provides an overview of the responsibilities of corporate organisations for both a...Inspired by Ida: In conversation with Lise Lotte Bundesen, Managing Director of the Ida Institute
The Ida Institue takes a collaborative approach to developing tools and resources that can be used by clinicians around the world to improve person-centred care. Their Managing Director Lise Lotte Bundesen tells us about their newest project, Inspired by Ida,...Global hearing rehabilitation – an SFORL/IFOS collaboration
International collaboration is more important than ever, and we hear from Prof Bernard Fraysse about a collaboration that grew out of the very successful IFOS meeting in Paris in 2017. The IFOS meeting in Paris in June 2017 was obviously...Treating voice disorders in singers
There are few ENT surgeons who have as much insight into singers’ problems as Nick Gibbins. A good knowledge of working patterns, repertoire and the physiology of ‘vocal athletes’ is essential. He shares a few thoughts with us. When deciding...Looking ahead to Liverpool – an interview with Sujata De
In preparation for the British Association for Paediatric Otorhinolaryngology (BAPO) conference in September, Grace Khong interviews Sujata De, a consultant paediatric ENT surgeon at Alder Hey Children’s NHS Foundation Trust. Miss De is BAPO president and National Children’s ENT lead...
Identification of congenital hearing loss in Saudi Arabia
It has long been recognised that timely recognition of congenital hearing loss allows for the morbidity of hearing loss to be minimised. Due to the difficulties with identifying hearing loss in babies, combined with readily available screening technologies, many countries...Developing medical devices for children: opportunities and challenges
The development of medical devices for infants and children lags significantly behind the development of devices for adults. While in the United States the Food and Drug Administration (FDA) has set up incentives for developing child age-specific pharmaceuticals, there is...
